CL2004001004A1 - Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple. - Google Patents

Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple.

Info

Publication number
CL2004001004A1
CL2004001004A1 CL200401004A CL2004001004A CL2004001004A1 CL 2004001004 A1 CL2004001004 A1 CL 2004001004A1 CL 200401004 A CL200401004 A CL 200401004A CL 2004001004 A CL2004001004 A CL 2004001004A CL 2004001004 A1 CL2004001004 A1 CL 2004001004A1
Authority
CL
Chile
Prior art keywords
revimid
multiple myeloma
pharmaceutical combination
treat multiple
includes irinotecan
Prior art date
Application number
CL200401004A
Other languages
English (en)
Inventor
David Emanuel
Sumant Ramachandra
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CL2004001004A1 publication Critical patent/CL2004001004A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200401004A 2003-05-19 2004-05-11 Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple. CL2004001004A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47160103P 2003-05-19 2003-05-19

Publications (1)

Publication Number Publication Date
CL2004001004A1 true CL2004001004A1 (es) 2005-03-18

Family

ID=33452451

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200401004A CL2004001004A1 (es) 2003-05-19 2004-05-11 Combinacion farmaceutica que comprende irinotecan y revimid para tratar el mieloma multiple.

Country Status (4)

Country Link
US (1) US20040266809A1 (es)
CL (1) CL2004001004A1 (es)
TW (1) TW200507840A (es)
WO (1) WO2004100953A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ526683A (en) 2000-11-30 2008-03-28 Childrens Medical Center Synthesis of 4-amino-thalidomide and its enantiomers that are suitable for inhibiting angiogenesis
US7393862B2 (en) 2002-05-17 2008-07-01 Celgene Corporation Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
USRE48890E1 (en) 2002-05-17 2022-01-11 Celgene Corporation Methods for treating multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione after stem cell transplantation
US7323479B2 (en) * 2002-05-17 2008-01-29 Celgene Corporation Methods for treatment and management of brain cancer using 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-methylisoindoline
WO2003097040A1 (en) 2002-05-17 2003-11-27 Celgene Corporation Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
KR20090048520A (ko) 2002-11-06 2009-05-13 셀진 코포레이션 암 및 다른 질환의 치료 및 관리를 위한 선택적 시토킨 억제 약물의 사용 방법 및 그 조성물
UA83504C2 (en) 2003-09-04 2008-07-25 Селджин Корпорейшн Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
EP1684758A4 (en) * 2003-11-06 2009-02-18 Celgene Corp METHODS AND COMPOSITIONS USING THALIDOMIDE FOR THE TREATMENT AND MANAGEMENT OF CANCERS AND OTHER DISEASES
CL2007002218A1 (es) * 2006-08-03 2008-03-14 Celgene Corp Soc Organizada Ba Uso de 3-(4-amino-1-oxo-1,3-dihidro-isoindol-2-il)-piperidina 2,6-diona para la preparacion de un medicamento util para el tratamiento de linfoma de celula de capa.
WO2012079075A1 (en) 2010-12-10 2012-06-14 Concert Pharmaceuticals, Inc. Deuterated phthalimide derivatives
WO2013130849A1 (en) 2012-02-29 2013-09-06 Concert Pharmaceuticals, Inc. Substituted dioxopiperidinyl phthalimide derivatives
US9249093B2 (en) 2012-04-20 2016-02-02 Concert Pharmaceuticals, Inc. Deuterated rigosertib
EP2922838B1 (en) 2012-10-22 2018-03-14 Concert Pharmaceuticals Inc. Solid forms of {s-3-(4-amino-1-oxo-isoindolin-2-yl)(piperidine-3,4,4,5,5-d5)-2,6-dione} .
WO2014110322A2 (en) 2013-01-11 2014-07-17 Concert Pharmaceuticals, Inc. Substituted dioxopiperidinyl phthalimide derivatives
JP2016519083A (ja) * 2013-03-14 2016-06-30 アンデス バイオテクノロジーズ ソシエダード アノニマＡｎｄｅｓ Ｂｉｏｔｅｃｈｎｏｌｏｇｉｅｓ Ｓ．Ａ． 多発性骨髄腫を検出および処置するための方法
US10034872B2 (en) 2014-08-22 2018-07-31 Celgene Corporation Methods of treating multiple myeloma with immunomodulatory compounds in combination with antibodies
HUE065109T2 (hu) 2015-06-26 2024-05-28 Celgene Corp Eljárások Kaposi-szarkóma vagy KSHV-indukált limfóma kezelésére immunomodulátor vegyületek alkalmazásával, valamint biomarkerek alkalmazása
US10537585B2 (en) 2017-12-18 2020-01-21 Dexcel Pharma Technologies Ltd. Compositions comprising dexamethasone

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE322266T1 (de) * 2000-05-15 2006-04-15 Celgene Corp Pharmazeutische zusammensetzungen zur behandlung von krebs welche thalidomid und topoisomerase inhibitoren enthalten
US7968569B2 (en) * 2002-05-17 2011-06-28 Celgene Corporation Methods for treatment of multiple myeloma using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione

Also Published As

Publication number Publication date
US20040266809A1 (en) 2004-12-30
WO2004100953A1 (en) 2004-11-25
TW200507840A (en) 2005-03-01

Similar Documents

Publication Publication Date Title
IL243709A0 (en) Devices, systems and methods for medicament delivery
BRPI0717389A2 (pt) Dispositivos e métodos para avanço de stent
DK1833532T3 (da) Sikkerhedssprøjte
BRPI0401856B1 (pt) método para gerenciar área florestal.
ES2398124T8 (es) Procedimiento y dispositivos para la modificación de sesión de terceros
BRPI0911612A2 (pt) composições e métodos para o tratamento da esclerose múltipla.
PT2054045E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento da artrite e da dor
NL1034745A1 (nl) Vaatstelselverdelingswerkwijzen en -apparatuur.
DK1835907T3 (da) Lægemidler til behandling eller forebyggelse af fibrotiske sygdomme
ITBO20050535A1 (it) Ugello per dispositivi estinguenti e simili
ITFI20060255A1 (it) Composizione agrochimica, e metodo di trattamento di vegetali conmprendente la somministrazione di tale composizione
ITBO20040803A1 (it) Apparecchiatura per la realizzazione di trattamenti antiparassitari.
CL2007002217A1 (es) Composicion farmaceutica que contiene saredutant con un inhibidor selectivo de la recaptacion de serotonina o con un inhibidor de la recaptacion de serotonina/norepinefrina; y uso en la prevencion y el tratamiento de un trastorno depresivo mayor.
BRPI0908602A2 (pt) método e composição farmacêutica para o tratamento de doenças autoimunes.
PT2117533E (pt) Composição farmacêutica à base de stachytarpheta sp., processo para a sua obtenção e sua utilização no tratamento de vitiligo
ES1061517Y (es) Protector erizo individual y colectivo para arboles y otras plantas.
ITMO20050089A1 (it) Dispositivo e metodo di protezione.
ES1062095Y (es) Dispositivo para la distribucion de medicamentos.
ES1057085Y (es) Disposicion retenedora para el poliposicionado de jamones y paletillas.
ES1057377Y (es) Estuche para piezas de joyeria y bisuteria.
DE102006040562B8 (de) Begasungssystem und -verfahren
ES1057389Y (es) Disposicion protectora para tronos procesionales.
ITCL20040002A1 (it) Sistema di protezione del cibo e dell
CL2007003284A1 (es) Composicion farmaceutica que comprende una asociacion de i) ciclobenzaprina, ii) aceclofenaco y opcionalmente iii) excipientes; y su uso para el tratamiento de enfermedades musculares dolorosas.
ITVR20060125A1 (it) Dispositivo e metodo per realizzare catene ornamentali.